Clinical Trial Update: Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety of Brimonidine/Timolol fixed combination in glaucoma and ocular hypertension. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED